Kala Pharmaceuticals Inc (KALA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $89,480
Last updated: Nov 17, 2026 at 10:57 AM ET
Kala Pharmaceuticals Inc (KALA) Earnings: Report Dates and Results
Kala Pharmaceuticals (KALA) is expected to report earnings on Nov 17, 2026. In the quarter ended Jun 30, 2026, Kala Pharmaceuticals reported EPS of -$21.32. It beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Next Report
KALA has an expected report date of Nov 17, 2026.
Earnings History
Of the 33 quarters below that had an estimate, KALA beat 16 and missed 17. The widest gap in the table came in the quarter ended Sep 30, 2023, when EPS landed 752.70% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | -$21.32 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Aug 19, 2026 | N/A |
| Mar 31, 2026 | -$0.14 | -$0.17 | -$0.17 - -$0.17 | N/A | N/A | N/A | 1 | N/A | Apr 15, 2026 | N/A |
| Sep 30, 2025 | -$53.50 | -$50.50 | -$50.50 - -$50.50 | -5.94% | Miss | N/A | 1 | 0 up, 1 down | Nov 19, 2025 | N/A |
| Jun 30, 2025 | -$65.94 | -$102.00 | -$102.00 - -$102.00 | +35.35% | Beat | N/A | 1 | 1 up, 0 down | Aug 8, 2025 | N/A |
| Mar 31, 2025 | -$50.66 | -$127.00 | -$127.00 - -$127.00 | +60.11% | Beat | N/A | 1 | 1 up, 0 down | May 14, 2025 | N/A |
| Dec 31, 2024 | -$1.23 | -$2.47 | -$2.47 - -$2.47 | +50.14% | Beat | N/A | 1 | 0 up, 1 down | Mar 31, 2025 | $254000 |
| Sep 30, 2024 | -$96.50 | -$135.50 | -$135.50 - -$107.50 | +28.78% | Beat | N/A | 2 | 0 up, 0 down | Nov 12, 2024 | N/A |
| Jun 30, 2024 | -$122.27 | -$229.00 | -$229.00 - -$211.50 | +46.61% | Beat | N/A | 2 | 0 up, 0 down | Aug 6, 2024 | N/A |
| Mar 31, 2024 | -$4.19 | -$2.89 | -$3.14 - -$2.64 | -44.98% | Miss | N/A | 2 | 0 up, 0 down | May 14, 2024 | N/A |
| Dec 31, 2023 | -$79.07 | -$200.00 | -$200.00 - -$154.00 | +60.47% | Beat | N/A | 3 | 0 up, 0 down | Mar 29, 2024 | $70000 |
| Sep 30, 2023 | -$150.12 | $23.00 | -$197.00 - $23.00 | -752.70% | Miss | N/A | 3 | 0 up, 0 down | Nov 13, 2023 | N/A |
| Jun 30, 2023 | -$174.05 | -$214.50 | -$266.00 - $25.00 | +18.86% | Beat | N/A | 3 | 0 up, 0 down | Aug 4, 2023 | N/A |
| Mar 31, 2023 | -$6.99 | -$4.52 | -$4.52 - -$4.52 | -54.65% | Miss | N/A | 1 | 0 up, 0 down | May 9, 2023 | N/A |
| Dec 31, 2022 | -$323.17 | -$382.50 | -$400.00 - -$255.50 | +15.51% | Beat | N/A | 2 | 0 up, 0 down | Mar 3, 2023 | $1.23M |
| Sep 30, 2022 | -$449.33 | $1,450.00 | -$600.00 - $1,675.00 | -130.99% | Miss | N/A | 2 | 0 up, 0 down | Nov 8, 2022 | $420000 |
| Jun 30, 2022 | -$872.50 | -$900.00 | N/A | +3.06% | Beat | N/A | 2 | 0 up, 0 down | Aug 11, 2022 | $2.10M |
| Mar 31, 2022 | -$1,001.00 | -$720.10 | N/A | -39.01% | Miss | N/A | 4 | 0 up, 0 down | May 16, 2022 | $1.37M |
| Dec 31, 2021 | -$34.00 | -$20.33 | -$22.00 - -$18.50 | -67.24% | Miss | N/A | 4 | N/A | Mar 29, 2022 | $1.86M |
| Sep 30, 2021 | -$925.00 | -$978.61 | -$1,175.00 - -$900.00 | +5.48% | Beat | N/A | 4 | 3 up, 0 down | Nov 15, 2021 | $3.07M |
| Jun 30, 2021 | -$1,000.00 | -$975.30 | -$1,225.00 - -$900.00 | -2.53% | Miss | N/A | 4 | N/A | Aug 5, 2021 | $3.05M |
| Mar 31, 2021 | -$1,025.00 | -$1,108.33 | -$4,850.00 - -$925.00 | +7.52% | Beat | N/A | 7 | N/A | May 5, 2021 | $3.27M |
| Dec 31, 2020 | -$27.50 | -$22.92 | -$25.50 - -$20.50 | -19.98% | Miss | N/A | 6 | N/A | Feb 25, 2021 | $2.24M |
| Sep 30, 2020 | -$1,250.00 | -$1,134.23 | -$1,275.00 - -$850.00 | -10.21% | Miss | N/A | 6 | N/A | Nov 5, 2020 | $2.22M |
| Jun 30, 2020 | -$1,050.00 | -$942.49 | -$1,400.00 - -$850.00 | -11.41% | Miss | N/A | 7 | N/A | Aug 6, 2020 | $833000 |
| Mar 31, 2020 | -$1,350.00 | -$1,500.00 | -$1,575.00 - -$750.00 | +10.00% | Beat | N/A | 5 | N/A | May 7, 2020 | $1.07M |
| Dec 31, 2019 | -$1,575.00 | -$1,556.46 | -$1,700.00 - -$1,150.00 | -1.19% | Miss | N/A | 3 | N/A | Feb 12, 2020 | $1.18M |
| Sep 30, 2019 | -$1,700.00 | -$1,619.39 | -$1,750.00 - -$1,550.00 | -4.98% | Miss | N/A | 3 | N/A | Nov 7, 2019 | $1.45M |
| Jun 30, 2019 | -$1,750.00 | -$1,853.70 | -$1,975.00 - -$1,750.00 | +5.59% | Beat | N/A | 5 | N/A | Aug 6, 2019 | $2.06M |
| Mar 31, 2019 | -$1,875.00 | -$2,013.42 | N/A | +6.87% | Beat | N/A | 5 | N/A | May 9, 2019 | $1.39M |
| Dec 31, 2018 | -$38.00 | -$26.10 | -$30.00 - -$22.50 | -45.59% | Miss | N/A | 5 | N/A | Mar 11, 2019 | N/A |
| Sep 30, 2018 | -$1,575.00 | -$1,600.00 | N/A | +1.56% | Beat | N/A | 4 | N/A | Nov 8, 2018 | N/A |
| Jun 30, 2018 | -$1,500.00 | -$1,233.33 | -$1,375.00 - -$1,150.00 | -21.62% | Miss | N/A | 4 | N/A | Aug 9, 2018 | N/A |
| Mar 31, 2018 | -$1,150.00 | -$1,157.39 | -$1,225.00 - -$1,025.00 | +0.64% | Beat | N/A | 3 | N/A | May 10, 2018 | N/A |
| Dec 31, 2017 | -$23.00 | -$18.50 | -$22.00 - -$13.50 | -24.32% | Miss | N/A | 4 | N/A | Mar 26, 2018 | N/A |
| Sep 30, 2017 | -$1,400.00 | -$1,062.50 | N/A | -31.76% | Miss | N/A | N/A | N/A | Nov 7, 2017 | N/A |
| Jun 30, 2017 | -$465.00 | -$26.67 | N/A | N/A | N/A | N/A | N/A | N/A | Aug 31, 2017 | N/A |
| Mar 31, 2017 | -$0.58 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 31, 2017 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2024 was -$224.19, after -$410.23 the year before. It was -$1,888.58 for the year ended Dec 31, 2017, the oldest of the 8 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2024 | -$224.19 | N/A |
| Dec 31, 2023 | -$410.23 | N/A |
| Dec 31, 2022 | -$2,646.00 | N/A |
| Dec 31, 2021 | -$2,984.00 | N/A |
| Dec 31, 2020 | -$3,677.50 | N/A |
| Dec 31, 2019 | -$6,900.00 | N/A |
| Dec 31, 2018 | -$4,263.00 | N/A |
| Dec 31, 2017 | -$1,888.58 | N/A |
Frequently Asked Questions About KALA
When is Kala Pharmaceuticals's next earnings date?
Kala Pharmaceuticals's next earnings report is expected for Nov 17, 2026.
How often does KALA beat earnings estimates?
Kala Pharmaceuticals beat the EPS estimate in 6 of the 8 most recent quarters that had an estimate, with an average surprise of +28.82%.
KALA pages: Overview, Earnings, Financials, Competitors